Biotech Insights Unlocked: Expert Talks on Investment, Deals & Growth
Stay ahead in the biotech industry with exclusive interviews, expert guest opinions, and strategic insights on biotech investment, valuation, venture capital, partnering, licensing, and commercialisation. Gain the knowledge and connections you need to accelerate growth and make informed business decisions.

Inside LSX World Congress
At the crossroads of biotech, medtech and pharmatech, the LSX World Congress brings together visionary founders, investors and industry leaders to shape the future of health innovation. From early-stage breakthroughs to digital pharma disruption, this is where strategic insight meets real-world impact.
Meet the CEOs
Meet the CEOs shaping biotech’s future. In this series, industry leaders share their visions, strategies, and insights on innovation, investment, and growth.
Deep Dive into LSX World Congress
Uncover the leading figures behind biotech investment and innovation, explore the process of shaping our agenda, and hear first-hand from attendees about their event experience. Learn from the investors who are defining the future of life sciences and discover what they’re seeking next.
Top Biotech Investors to Watch at LSX World Congress
Get a complete insight into what our attendees have been saying about LSX World Congress

Join the Community
Follow us on LinkedIn for exclusive insights into event content, daily updates on the latest happenings, and more.
Don’t miss a moment—join the conversation today!
FAQs
Who should attend the Biotech Leaders track?
The track is designed for senior executives and decision makers in the biotech/life sciences ecosystem – including founders and CEOs of biotech companies, investors (VCs, crossover funds, corporate venture), tech transfer professionals from academia, and service providers supporting biotech innovation.
What are the main themes of the Biotech Leaders agenda?
The Biotech track covers three strategic themes:
- Early Innovation & Technology Translation
- Capital Markets & Investment Strategies
- Market Opportunities & Commercialisation
What topics does the Early Innovation & Technology track cover?
This track explores:
- Next-generation modalities beyond antibodies
- Rare disease vs. broad indication strategies
- Platform technologies and academic spinout pathways
- Global innovation hubs and lab-to-launch commercialization
- Biotech entrepreneurship lessons
Are there specialized sessions for different stages of biotech companies?
Yes, the agenda includes:
- Exclusive CEO forums for early-stage biotech companies
- Growth-stage biotech company discussions
- Closed-door sessions for candid discussions about pressing challenges
- Partnership strategy sessions for companies suitable for pharmaceutical partnerships








